Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114351320> ?p ?o ?g. }
- W2114351320 endingPage "747" @default.
- W2114351320 startingPage "733" @default.
- W2114351320 abstract "Introduction : Multiple myeloma (MM) is a B-cell malignancy characterized by proliferation of monoclonal plasma cells in the bone marrow. Although new therapeutic options have been introduced and response rates have improved in recent years, MM still remains incurable and new treatment options are urgently needed. The histone deacetylase inhibitors (HDACi) are a new class of anticancer agents in early clinical development in many malignancies including MM. HDACi target the enzyme histone deacetylase (HDAC) involved in the deacetylation of histone and non-histone cellular proteins that play important roles in epigenetic regulation of gene expression inducing death, apoptosis and cell cycle arrest in cancer cells. Panobinostat (LBH589) is a highly potent HDACi with demonstrated antitumor activities at low nanomolar concentration in several preclinical studies and its clinical efficacy is currently under investigation in several clinical trials. Area covered : In this review the authors discuss the role of HDACs in the regulation of gene expression and the biological mechanisms mediating the anticancer effects of HDACi with particular focus on the recent development of panobinostat as anti-MM agent in preclinical and clinical studies. Expert opinion : As a ‘multi-target' drug, panobinostat appears attractive as potential anti-MM therapeutic for its ability to modulate a variety of biological pathways essential in MM biology. This ‘multi-target' property of panobinostat may also be one its major shortcomings, and a better understanding of its mechanisms of action and targets will permit to identify the best combination therapies that will ultimately overcome and improve outcomes in MM patients." @default.
- W2114351320 created "2016-06-24" @default.
- W2114351320 creator A5023276777 @default.
- W2114351320 creator A5064430852 @default.
- W2114351320 creator A5065238694 @default.
- W2114351320 date "2012-03-12" @default.
- W2114351320 modified "2023-10-17" @default.
- W2114351320 title "Panobinostat for the treatment of multiple myeloma" @default.
- W2114351320 cites W1493846190 @default.
- W2114351320 cites W1521206796 @default.
- W2114351320 cites W1567485746 @default.
- W2114351320 cites W1574682683 @default.
- W2114351320 cites W1687504009 @default.
- W2114351320 cites W1967018540 @default.
- W2114351320 cites W1968068668 @default.
- W2114351320 cites W1968972540 @default.
- W2114351320 cites W1972149587 @default.
- W2114351320 cites W1973006537 @default.
- W2114351320 cites W1975692560 @default.
- W2114351320 cites W1976662121 @default.
- W2114351320 cites W1977261522 @default.
- W2114351320 cites W1981591956 @default.
- W2114351320 cites W1991660464 @default.
- W2114351320 cites W1992538067 @default.
- W2114351320 cites W1993655008 @default.
- W2114351320 cites W1995902306 @default.
- W2114351320 cites W1999275729 @default.
- W2114351320 cites W2004980848 @default.
- W2114351320 cites W2009204250 @default.
- W2114351320 cites W2010833137 @default.
- W2114351320 cites W2011982830 @default.
- W2114351320 cites W2018750602 @default.
- W2114351320 cites W2022285476 @default.
- W2114351320 cites W2024425375 @default.
- W2114351320 cites W2024834376 @default.
- W2114351320 cites W2029598062 @default.
- W2114351320 cites W2031046263 @default.
- W2114351320 cites W2031671750 @default.
- W2114351320 cites W2047794102 @default.
- W2114351320 cites W2048722552 @default.
- W2114351320 cites W2052169053 @default.
- W2114351320 cites W2053344100 @default.
- W2114351320 cites W2057358066 @default.
- W2114351320 cites W2057551317 @default.
- W2114351320 cites W2059948085 @default.
- W2114351320 cites W2062561914 @default.
- W2114351320 cites W2066052727 @default.
- W2114351320 cites W2068213179 @default.
- W2114351320 cites W2068331698 @default.
- W2114351320 cites W2072375912 @default.
- W2114351320 cites W2081973434 @default.
- W2114351320 cites W2083784041 @default.
- W2114351320 cites W2084326063 @default.
- W2114351320 cites W2086384126 @default.
- W2114351320 cites W2086799752 @default.
- W2114351320 cites W2087507084 @default.
- W2114351320 cites W2087966689 @default.
- W2114351320 cites W2088553641 @default.
- W2114351320 cites W2090926709 @default.
- W2114351320 cites W2092722802 @default.
- W2114351320 cites W2096083625 @default.
- W2114351320 cites W2097217800 @default.
- W2114351320 cites W2099262276 @default.
- W2114351320 cites W2100256432 @default.
- W2114351320 cites W2100972878 @default.
- W2114351320 cites W2102650381 @default.
- W2114351320 cites W2110894784 @default.
- W2114351320 cites W2114468318 @default.
- W2114351320 cites W2117867145 @default.
- W2114351320 cites W2118335184 @default.
- W2114351320 cites W2123639512 @default.
- W2114351320 cites W2123927456 @default.
- W2114351320 cites W2124560610 @default.
- W2114351320 cites W2131331729 @default.
- W2114351320 cites W2132880072 @default.
- W2114351320 cites W2135085078 @default.
- W2114351320 cites W2138984926 @default.
- W2114351320 cites W2139849891 @default.
- W2114351320 cites W2140078074 @default.
- W2114351320 cites W2141410747 @default.
- W2114351320 cites W2141639822 @default.
- W2114351320 cites W2142112710 @default.
- W2114351320 cites W2146320180 @default.
- W2114351320 cites W2146450812 @default.
- W2114351320 cites W2149386327 @default.
- W2114351320 cites W2150642119 @default.
- W2114351320 cites W2151071075 @default.
- W2114351320 cites W2151445954 @default.
- W2114351320 cites W2156712995 @default.
- W2114351320 cites W2157228274 @default.
- W2114351320 cites W2159959495 @default.
- W2114351320 cites W2160538256 @default.
- W2114351320 cites W2162934657 @default.
- W2114351320 cites W2164106976 @default.
- W2114351320 cites W2167118090 @default.
- W2114351320 cites W2169508075 @default.
- W2114351320 cites W2318410985 @default.
- W2114351320 cites W2566626795 @default.